People who have been taking antidepressants for more than two years are substantially more likely to experience withdrawal symptoms compared…
Read More »antidepressant
Spravato, the brand name for esketamine, has a newly approved indication for treatment-resistant depression. tadamichi/Getty Images/iStockphoto/iStockphoto hide caption toggle caption…
Read More »